status of the company:
joint stock company
President of Koncern:
of HEMOFARM is production of
application of state-of-art technologies the company in 2001 reached the record
level of drugs' production - 91 million packagins - that was three times more
than 10 years ago.
offers the wide range of products inside the following production divisions:
for human use
300 galenical preparations for human use in which antibiotics,
cardiovascular preparations and neuroleptics have the major share
solutions (simple and complex) and preparations for enteral and parenteral
products (injectables and solutions)
and its subsidiary enterprise HEMOMED since 1982 have been
developing production programme of medical materials intended for use in
hemodialysis. Production is carried out in plants located in Vrsac and Srpska
solutions and concetrated solutions for hemodialysis
and transfusion systems
products and crop protection agents
subsidiary company Hemovet has been producing veterinary medicaments
since 1993, whereas it has developed a crop protection agents production since
1997. Production is carried out in plants located in Vrsac and Backi Petrovac.
products programme includes 90 drugs from all groups.
protection agents programme includes 27 herbicides,
fungicides, incecticides and agents for communal hygiene.
plastic products intended for use in food industry, pharmaceutical
industry and textile industry.
pads intended for use in confectionery industry (packaging material
for candy boxes).
Group is made of parent company and 21 subsidiaries, of which 12 are in
Yugoslavia, and the others are abroad.
materializes its domestic production performance in modern production plants
located in Vrsac, Dubovac, Jasenovo, Srpska Crnja, Podgorica and Backi Petrovac.
has also developed a very wide spectrum of activities in the field of marketing,
export-import, wholesale and retail trade, as well as transfer of technology,
engineering and realization of turn-key projects.
Consumption of raw materials:
Linomycin Hcl, Gentamycin sulphate, Ascorbic Acid,
Sulphamethoxazole, Trimethoprime, Glucose Monohydrate pyrogens free, Mannitol
pyrogens free, Sorbitol liquide, Calcium Chloride, Ibuprofen,
HEMOFARM sales about 75% of its products at
has the leading position at domestic drug market with the share of 41.4% in
sales about 25% of its products at export markets. In 2001 it realized a
following structure of export by destination: Russian Federation 41.6%,
Macedonia 15.8%, Republic Srpska 13.6%, Irak 9.1%, Romania 5.4%, Slovenia 3.0%,
Main export programme are drugs for human use, as Enalapril
(tbl 10 mg and 20 mg), Hidrokortizon (inj 100 mg), Dilcoran (80
tbl), Physiological solution (500 ml) and Diklofenak (tbl 100 mg).
road and railway (Belgrade - Pancevo - Vrsac)
has on disposal its own vehicles for domestic and international transport and it
is the member of International Organization for Transport of Goods.
Quality assurance certification:ISO 9002 approval issued in 1996
introduction of ISO 14000 standards under way
Average turnover:150 mil. $
of export:30 mil. $
increase of production and sales by 20%